Metformin is an insulin sensitizing drug routinely used for the treatment of anovulatory
patients with polycystic ovary syndrome (PCOS). To date, the metabolic effects of the
long-term metformin administration are know but no data are available on the effects after
its suspension.
The purpose of this study is to evaluate the effects of metformin suspension on insulin
sensitivity in PCOS patients.